These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. Kurzrock R; Talpaz M; Gutterman JU Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3. Dunbar CE; Smith DA; Kimball J; Garrison L; Nienhuis AW; Young NS Br J Haematol; 1991 Oct; 79(2):316-21. PubMed ID: 1958491 [TBL] [Abstract][Full Text] [Related]
5. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Sieff C; Guinan E Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia. Guinan EC; Lopez KD; Huhn RD; Felser JM; Nathan DG J Pediatr; 1994 Jan; 124(1):144-50. PubMed ID: 8283365 [TBL] [Abstract][Full Text] [Related]
7. Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. Estey EH; Kurzrock R; Talpaz M; McCredie KB; O'Brien S; Kantarjian HM; Keating MJ; Deisseroth AB; Gutterman JU Br J Haematol; 1991 Mar; 77(3):291-5. PubMed ID: 2012752 [TBL] [Abstract][Full Text] [Related]
8. Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients. Kurzrock R; Talpaz M; Gomez JA; Estey EH; O'Brien S; Hirsch-Ginsberg C; Koller C; Freireich EJ; Gutterman JU Br J Haematol; 1991 Jul; 78(3):352-8. PubMed ID: 1873220 [TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony stimulating factor (rh-GM-CSF) in the treatment of chemotherapy-induced neutropenia. Gözdasoglu S; Unal E; Yavuz G; Pamir A; Reisli I; Deda G; Tarcan A; Babacan E; Cavdar AO J Chemother; 1995 Oct; 7(5):467-9. PubMed ID: 8596135 [TBL] [Abstract][Full Text] [Related]
10. Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids. López-Karpovitch X; Ulloa-Aguirre A; von Eiff C; Hurtado-Monroy R; Alanis A Acta Haematol; 1992; 87(3):148-50. PubMed ID: 1642096 [TBL] [Abstract][Full Text] [Related]
11. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study. Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial. Khwaja A; Linch DC; Goldstone AH; Chopra R; Marcus RE; Wimperis JZ; Russell NH; Haynes AP; Milligan DW; Leyland MJ Br J Haematol; 1992 Oct; 82(2):317-23. PubMed ID: 1419813 [TBL] [Abstract][Full Text] [Related]
13. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia. Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [TBL] [Abstract][Full Text] [Related]
15. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia. Chap L; Schiller G; Nimer SD Bone Marrow Transplant; 1993 Aug; 12(2):173-5. PubMed ID: 8401368 [TBL] [Abstract][Full Text] [Related]
16. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578 [TBL] [Abstract][Full Text] [Related]
19. Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia. Gordon-Smith EC; Yandle A; Milne A; Speck B; Marmont A; Willemze R; Kolb H Bone Marrow Transplant; 1991; 7 Suppl 2():78-80. PubMed ID: 1878731 [No Abstract] [Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]